Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.verified

ENSC

Price:

$8.26

Market Cap:

$10.78M

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection agains...[Read more]

Industry

Biotechnology

IPO Date

2018-03-14

Stock Exchange

NASDAQ

Ticker

ENSC

The Enterprise Value as of December 2024 (TTM) for Ensysce Biosciences, Inc. (ENSC) is 7.01M

According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.01M. This represents a change of -85.73% compared to the average of 49.14M of the last 4 quarters.

Ensysce Biosciences, Inc. (ENSC) Historical Enterprise Value (quarterly & annually)

How has ENSC Enterprise Value performed in the past?

The mean historical Enterprise Value of Ensysce Biosciences, Inc. over the last ten years is 2.21B. The current 7.01M Enterprise Value has changed -68.20% with respect to the historical average. Over the past ten years (40 quarters), ENSC's Enterprise Value was at its highest in in the March 2020 quarter at 250.39B. The Enterprise Value was at its lowest in in the September 2024 quarter at 31.84M.

Quarterly (TTM)
Annual

Average

2.21B

Median

2.95B

Minimum

25.55M

Maximum

3.69B

Ensysce Biosciences, Inc. (ENSC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ensysce Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 39.84%

Maximum Annual Enterprise Value = 3.69B

Minimum Annual Increase = -98.20%

Minimum Annual Enterprise Value = 25.55M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202335.73M39.84%
202225.55M-98.20%
20211.42B-51.72%
20202.95B-20.09%
20193.69B0.27%
20183.68B0.82%

Ensysce Biosciences, Inc. (ENSC) Average Enterprise Value

How has ENSC Enterprise Value performed in the past?

The current Enterprise Value of Ensysce Biosciences, Inc. (ENSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

494.45M

5-year avg

1.62B

10-year avg

2.21B

Ensysce Biosciences, Inc. (ENSC) Enterprise Value vs. Peers

How is ENSC’s Enterprise Value compared to its peers?

Ensysce Biosciences, Inc.’s Enterprise Value is greater than Zura Bio Limited (-32822399.00), greater than Phio Pharmaceuticals Corp. (-3036859.00), greater than Sonnet BioTherapeutics Holdings, Inc. (4.31M), greater than 180 Life Sciences Corp. (3.98M), less than Cardio Diagnostics Holdings, Inc. (40.39M), greater than Virax Biolabs Group Limited (4.97M), less than Blue Water Vaccines, Inc. (12.55M), greater than Revelation Biosciences, Inc. (-4014046.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (4.31M), greater than Quoin Pharmaceuticals, Ltd. (-480796.00), greater than Allarity Therapeutics, Inc. (-12515070.00), less than Kiromic BioPharma, Inc. (13.21M), less than Biodexa Pharmaceuticals Plc (703.41M), greater than PaxMedica, Inc. Common Stock (394.63K),

Build a custom stock screener for Ensysce Biosciences, Inc. (ENSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ensysce Biosciences, Inc. (ENSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ensysce Biosciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ensysce Biosciences, Inc. (ENSC)?

What is the 3-year average Enterprise Value for Ensysce Biosciences, Inc. (ENSC)?

What is the 5-year average Enterprise Value for Ensysce Biosciences, Inc. (ENSC)?

How does the current Enterprise Value for Ensysce Biosciences, Inc. (ENSC) compare to its historical average?